Keith Flaherty is Director of Clinical Research at the Massachusetts General Hospital Cancer Center and Professor of Medicine at Harvard Medical School.Keith T. Flaherty, MD - Massachusetts General Hospital, Boston, MA He was previously a professor of medicine at the University of Pennsylvania. He is known for his research on targeted therapies for cancer, and in particular for his work on the melanoma drug vemurafenib.Target Cancer - A Roller Coaster Chase for a Cure - Series - NYTimes.comTarget Cancer - After Long Fight, Melanoma Drug Gives Sudden Reprieve - Series - NYTimes.comTarget Cancer - A Drug Trial Cycle - Recovery, Relapse, Reinvention - Series - NYTimes.comInhibition of Mutated, Activated BRAF in Metastatic Melanoma — NEJM In 2013, Massachusetts General Hospital partnered with AstraZeneca to partner Flaherty's research into developing a formula to identify vulnerabilities of tumors with AstraZeneca's library of drugs.
References